Variable | Patients with TLE | Controls (n = 37) | ||||
---|---|---|---|---|---|---|
Refractory (n = 17) | Well controlled (n = 20) | |||||
AED, anti-epileptic drug; CBZ, carbamazepine; OXC, oxcarbazepine. | ||||||
Age (years, mean (SD)) | 32.1 (7.2) | 32.2 (6.6) | 32.2 (8.3) | |||
Men/women | 4/13 | 9/11 | 13/24 | |||
Duration of TLE (years, mean (SD)) | 22.7 (10.0) | 14.2 (10.1) | – | |||
Seizure characteristics | ||||||
Seizure free (no. of patients) | – | 11 | – | |||
Seizure per month (mean (SD)) | 20.3 (38.2) | 0.03 (0.07) | – | |||
Antiepileptic medication | ||||||
Monotherapy | ||||||
Carbamazepine | – | 10 | – | |||
Oxcarbazepine | 4 | 7 | – | |||
Phenytoin | – | 1 | – | |||
Lamotrigine | – | 1 | – | |||
Polytherapy | ||||||
CBZ with other AED(s) | 7 | 1 | – | |||
OXC with other AED(s) | 6 | – | – |